AC Immune SA (ACIU)
2.39
-0.05
(-2.05%)
USD |
NASDAQ |
May 03, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
AC Immune Free Cash Flow: -68.17M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -68.17M |
| September 30, 2023 | -69.83M |
| June 30, 2023 | -67.95M |
| March 31, 2023 | -71.15M |
| December 31, 2022 | -78.44M |
| September 30, 2022 | -79.93M |
| June 30, 2022 | -81.85M |
| March 31, 2022 | -80.35M |
| December 31, 2021 | -74.76M |
| September 30, 2021 | -74.95M |
| June 30, 2021 | -77.40M |
| March 31, 2021 | -75.12M |
| December 31, 2020 | -65.30M |
| September 30, 2020 | -58.54M |
| June 30, 2020 | -22.36M |
| March 31, 2020 | -22.26M |
| December 31, 2019 | 53.68M |
| Date | Value |
|---|---|
| September 30, 2019 | 55.20M |
| June 30, 2019 | 25.30M |
| March 31, 2019 | 33.96M |
| December 31, 2018 | -46.96M |
| September 30, 2018 | -27.34M |
| June 30, 2018 | -23.79M |
| March 31, 2018 | -27.03M |
| December 31, 2017 | -24.26M |
| September 30, 2017 | -38.74M |
| June 30, 2017 | -21.68M |
| March 31, 2017 | -11.13M |
| December 31, 2016 | -6.644M |
| September 30, 2016 | -4.988M |
| June 30, 2016 | 20.90M |
| March 31, 2016 | 16.27M |
| December 31, 2015 | 45.56M |
Free Cash Flow Range, Past 5 Years
-81.85M
Minimum
Jun 2022
55.20M
Maximum
Sep 2019
-49.17M
Average
-69.83M
Median
Sep 2023
Free Cash Flow Benchmarks
| CRISPR Therapeutics AG | -272.34M |
| Addex Therapeutics Ltd | -8.908M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -66.61M |
| MoonLake Immunotherapeutics | -42.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.21M |
| Cash from Investing (Quarterly) | 25.14M |
| Cash from Financing (Quarterly) | 45.65M |
| Free Cash Flow Per Share (Quarterly) | -0.2004 |
| Free Cash Flow to Equity (Quarterly) | -17.38M |
| Free Cash Flow to Firm (Quarterly) | -17.38M |
| Free Cash Flow Yield | -33.58% |